Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

C>A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: a non-deletional mutation or polymorphism?

Ropero P, González FA, Nieto JM, Villegas A, Sevilla J, Pérez G, Alonso JM, Recasens V, Abio M, Vagace JM, Vanegas RJ, González Fernández B, Martínez R.

J Clin Pathol. 2019 Aug 21. pii: jclinpath-2019-206004. doi: 10.1136/jclinpath-2019-206004. [Epub ahead of print]

PMID:
31434698
2.

Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.

Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J, Balagué O, Celis V, Verdu-Amoros J, Nadeu F, Sábado C, Ferrández A, Garrido M, García-Bragado F, de la Maya MD, Vagace JM, Panizo CM, Astigarraga I, Andrés M, Jaffe ES, Campo E, Salaverria I.

Haematologica. 2019 Sep;104(9):1822-1829. doi: 10.3324/haematol.2018.207928. Epub 2019 Feb 7.

3.

Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.

Gervasini G, de Murillo SG, Jiménez M, de la Maya MD, Vagace JM.

J Pediatr Hematol Oncol. 2017 Nov;39(8):589-595. doi: 10.1097/MPH.0000000000000908.

PMID:
28719513
4.

Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia.

Gervasini G, de Murillo SG, Jiménez M, de la Maya MD, Vagace JM.

Gene. 2017 Sep 10;628:72-77. doi: 10.1016/j.gene.2017.07.025. Epub 2017 Jul 12.

PMID:
28710036
5.

Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.

Vagace JM, Cardesa R, Corbacho A, Vázquez T, de la Maya MD, Gonzalez FA, Nieto JB, Urrutia E, Gómez MJ, Pascual T, Aguinaco MR, Gervasini G.

Ann Hematol. 2016 Sep;95(9):1419-27. doi: 10.1007/s00277-016-2733-8. Epub 2016 Jul 9.

PMID:
27392662
6.

Functional consequences of transferrin receptor-2 mutations causing hereditary hemochromatosis type 3.

Joshi R, Shvartsman M, Morán E, Lois S, Aranda J, Barqué A, de la Cruz X, Bruguera M, Vagace JM, Gervasini G, Sanz C, Sánchez M.

Mol Genet Genomic Med. 2015 May;3(3):221-32. doi: 10.1002/mgg3.136. Epub 2015 Mar 6.

7.

Clinical relevance of erythrocyte ferritin in microcytic anemias.

Vagace JM, Peças A, Groiss J, Bento C, Ribeiro ML, Gervasini G.

Clin Chim Acta. 2015 Mar 10;442:1-5. doi: 10.1016/j.cca.2014.12.035. Epub 2015 Jan 3.

PMID:
25562818
8.

Thalassemia diagnosis in a blood donor from a unique trimorphic red blood cell population observed in the recipient.

Vagace JM, de la Maya MD, Gervasini G.

Clin Chem Lab Med. 2014 Sep;52(9):e205-6. doi: 10.1515/cclm-2014-0248. No abstract available.

PMID:
24781676
9.

Diagnostic and therapeutic challenges of primary autoimmune haemolytic anaemia in children.

Vagace JM, Bajo R, Gervasini G.

Arch Dis Child. 2014 Jul;99(7):668-73. Epub 2014 Mar 5. Review.

PMID:
24599068
10.

Hyperhaemolysis syndrome responsive to splenectomy in a patient with δβ-thalassaemia: a discussion on underlying mechanisms.

Vagace JM, Casado MS, Bajo R, Gervasini G.

Blood Transfus. 2014 Jan;12(1):127-9. doi: 10.2450/2013.0059-13. Epub 2013 Nov 15. No abstract available.

11.

Ethylenediaminetetraacetic acid-dependent pseudomacrocytosis.

Vagace JM, Rodriguez MÁ, de la Maya MD, Gervasini G.

J Clin Pathol. 2013 Sep;66(9):811-4. doi: 10.1136/jclinpath-2013-201545. Epub 2013 May 30.

PMID:
23723302
12.

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.

Gervasini G, Vagace JM.

Front Genet. 2012 Nov 22;3:249. doi: 10.3389/fgene.2012.00249. eCollection 2012.

13.

Diagnostic utility of HFE variants in Spanish patients: association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia.

Rodríguez-López R, Donoso M, Fernández-Cavada M, González LM, Margallo A, Corral C, Gallego M, García de Cáceres MT, Herrera T, González C, Vagace JM, Gervasini G.

Gene. 2013 Feb 1;514(1):31-5. doi: 10.1016/j.gene.2012.10.090. Epub 2012 Nov 21.

PMID:
23178241
14.

Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma.

Vagace JM, de la Maya MD, Caceres-Marzal C, Gonzalez de Murillo S, Gervasini G.

Crit Rev Oncol Hematol. 2012 Nov;84(2):274-86. doi: 10.1016/j.critrevonc.2012.04.003. Epub 2012 May 11. Review.

PMID:
22578745
15.

Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.

Vagace JM, Caceres-Marzal C, Jimenez M, Casado MS, de Murillo SG, Gervasini G.

Am J Hematol. 2011 Jan;86(1):98-101. doi: 10.1002/ajh.21897.

16.

Chronic haemolytic anaemia because of pyruvate kinase (PK) deficiency in a child heterozygous for haemoglobin S and no clinical features of sickle cell disease.

Manco L, Vagace JM, Relvas L, Rebelo U, Bento C, Villegas A, Letícia Ribeiro M.

Eur J Haematol. 2010 Jan 1;84(1):89-90. doi: 10.1111/j.1600-0609.2009.01353.x. Epub 2009 Sep 16. Review. No abstract available.

PMID:
19758413
17.

Retinal toxic reactions following photopheresis.

Vagace JM, Gervasini G, Morais F, Benitez J, Alonso N, de Argila D, Arranz I, Bajo R.

Arch Dermatol. 2007 May;143(5):622-5.

PMID:
17515512
18.

Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.

Vagace JM, Sanz-Rodriguez C, Casado MS, Alonso N, Garcia-Dominguez M, de la Llana FG, Zarallo L, Fajardo M, Bajo R.

BMC Infect Dis. 2007 May 10;7:40.

19.

Aplastic anemia during treatment with albendazole.

Fernández FJ, Rodríguez-Vidigal FF, Ledesma V, Cabanillas Y, Vagace JM.

Am J Hematol. 1996 Sep;53(1):53-4. No abstract available.

20.

Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy.

Caravaca F, Vagace JM, Aparicio A, Groiss J, Pizarro JL, Alonso N, Garcia MC, Arrobas M, Cubero J, Esparrago J, et al.

Am J Kidney Dis. 1992 Sep;20(3):249-54.

PMID:
1519605

Supplemental Content

Loading ...
Support Center